DNA Methylation Market by Product Type, Distribution Channel, End User 2024-2032
                     Global DNA Methylation 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t h e  l a t e s t  r ep o r t  by  I M AR C G r o up ,  t i t l ed  " D NA M et hy l a t i on  M arke t :  
G l o ba l  I ndu st ry  T re nds ,  Sh are ,  S i ze ,  G row t h ,  O pp or t u n i t y  an d  Fo recas t  20 24 -
2032 , "  t he  g loba l  DNA  m e t hy la t i on  m ar k e t  s i z e  r ea ched  US$  1 . 4  B i l l i on  i n  202 3 .
Deox y r i bon uc le i c  ac id  ( DNA)  m e t hy la t i on  r e f e r s  t o  a  b io log i c a l  p r o cess  i n  w h ich  a  
m e t hy l  g r ou p  i s  added  t o  t he  cy t os ine  ba se  o f  a  DNA m o l ecu le .  I t  i s  an  ep igen e t i c  
Report m od i f i ca t i on  p r oc ess  t h a t  a l t e r s  gene  e xp r e ss ion  pa t t e r ns  w i t hou t  c hang ing  t he  
unde r l y i ng  D NA sequ ence .  I t  i s  ana l yzed  t h r oug h  va r i ous  t ec hno log ies ,  su ch  as  
Highlight and po lym er as e  cha in  r eac t i on  ( PCR ) ,  m ic r o a r r ay ,  b is u l f i t e  seq uenc i ng ,  im m unopr ec ip i t a t i on  ( I P ) ,  an d  nan opo r e  se quenc ing .  
DNA m e t hy la t i on  i s  w ide l y  u sed  f o r  d i sea se  d iag nos i s  an d  p r o gnos is ,  p r ena t a l  
Description sc r e en ing ,  d r ug  deve lo pm e n t ,  ep ig ene t i c  r esea r ch ,  a nd  f o r ens i c  an a l ys i s .  I t  
p r ov ides  a  de epe r  u nde r s t and ing  o f  d i seas e  m ec han is m s  a nd  p r o g r es s ion ,  w h ich  
a ids  i n  ea r l y  d i sea se  de t ec t i on ,  im p r ov ing  c l i n i ca l  ou t com es ,  m in im iz ing  
com p l i ca t io ns ,  and  enhan c ing  p a t i e n t  s a t i s f a c t i on .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / dna - m e t hy la t i on - m ar ke t / r e ques t sam p le
Report Description
G l o b a l  D N A  M e t h y l a t i o n  M a r k e t  T r e n d s :
T h e  e s c a l a t i n g  p r e v a l e n c e  o f  c h r o n i c  d i s e a s e s ,  s u c h  a s  c a n c e r ,  d i a b e t e s ,  h y p e r t e n s i o n ,  a r t h r i t i s ,  A l z h e i m e r ’ s  d i s e a s e ,  a n d  
c a r d i o v a s c u l a r  d i s e a s e s  ( C V D s ) ,  i s  o n e  o f  t h e  k e y  f a c t o r s  d r i v i n g  t h e  m a r k e t  g r o w t h .  D N A  m e t h y l a t i o n  i s  w i d e l y  u s e d  a s  a  b i o m a r k e r  t o  
i d e n t i f y  e p i g e n e t i c  c h a n g e s  a s s o c i a t e d  w i t h  c e r t a i n  c o n d i t i o n s ,  t h u s  a l l o w i n g  e a r l y  d i s e a s e  d e t e c t i o n ,  i m p r o v i n g  p a t i e n t  o u t c o m e s ,  a n d  
r e d u c i n g  h e a l t h c a r e  c o s t s .  I n  a d d i t i o n  t o  t h i s ,  t h e  r i s i n g  g e r i a t r i c  p o p u l a t i o n  w i t h  h i g h  s u s c e p t i b i l i t y  t o  d e v e l o p i n g  c h r o n i c  c o n d i t i o n s  i s  
a c t i n g  a s  a n o t h e r  g r o w t h - i n d u c i n g  f a c t o r .  F u r t h e r m o r e ,  t h e  i n c r e a s i n g  a d o p t i o n  o f  D N A  m e t h y l a t i o n  a s  a  n o n - i n v a s i v e  d i a g n o s t i c  t o o l  
f o r  m o n i t o r i n g  d i s e a s e s ,  w h i c h  e n h a n c e s  p a t i e n t  c o m f o r t  a n d  r e d u c e s  t h e  r i s k  o f  c o m p l i c a t i o n s ,  i s  p r o v i d i n g  a n  i m p e t u s  t o  t h e  m a r k e t  
g r o w t h .  A d d i t i o n a l l y ,  t h e  r e c e n t  d e v e l o p m e n t  o f  s i n g l e - c e l l  s e q u e n c i n g  t e c h n o l o g y  t h a t  a l l o w s  f a s t ,  m o r e  a c c u r a t e ,  a n d  i n - d e p t h  
a n a l y s i s  o f  D N A  m e t h y l a t i o n  p a t t e r n s  i s  p o s i t i v e l y  i n f l u e n c i n g  t h e  m a r k e t  g r o w t h .  M o r e o v e r ,  t h e  i n c r e a s i n g  a p p l i c a t i o n s  o f  D N A  
m e t h y l a t i o n  i n  p r e n a t a l  s c r e e n i n g  t o  d e t e c t  c h r o m o s o m a l  a b n o r m a l i t i e s  a n d  i d e n t i f y  v a r i o u s  g e n e t i c  d i s o r d e r s ,  s u c h  a s  d o w n  s y n d r o m e ,  
m u s c u l a r  d y s t r o p h y ,  a n d  c y s t i c  f i b r o s i s ,  i s  f a c i l i t a t i n g  t h e  m a r k e t  g r o w t h .  O t h e r  f a c t o r s ,  i n c l u d i n g  r i s i n g  h e a l t h c a r e  e x p e n d i t u r e ,  t h e  
i n c r e a s i n g  u t i l i z a t i o n  o f  D N A  m e t h y l a t i o n  t o  d e v e l o p  n e w  p l a n t  v a r i e t i e s ,  e x t e n s i v e  r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s ,  a n d  
g r o w i n g  d e m a n d  f o r  p r e c i s i o n  m e d i c i n e ,  a r e  a n t i c i p a t e d  t o  d r i v e  t h e  m a r k e t  g r o w t h .
L o o k i n g  f o r w a r d ,  t h e  m a r k e t  v a l u e  i s  e x p e c t e d  t o  r e a c h  U S $  4 . 5  B i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  C A G R  o f  1 3 . 5 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / d n a - m e t h y l a t i o n - m a r k e t
Breakup by Product:
• Consumables
• Kits and Reagents
• Enzymes
• Instrument and Software
Report Breakup by Technology:
Segmentation • Polymerase Chain Reaction (PCR)
• Microarray
• Sequencing
• Others
Breakup by Application:
• Gene Therapy
• Cl in ical  Research
• Diagnost ics
• Others
Breakup by End User:
• Hospita l  and Diagnost ic  Laborator ies
Report • Pharmaceut ical  and Biotechnology Companies
Segmentation • Research and Academia
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in Amer ica
• Middle East  and Afr ica
• Abcam plc.
• Active Moti f  Inc.
• Diagenode S.A. (Hologic Inc.)
Competitive • EpiGentek Group Inc.
Landscape • I l lumina Inc.
• Merck KGaA
with Key • New England Biolabs Inc.
Players • PerkinElmer Inc.
• Qiagen N.V.
• Thermo-Fisher Scientifi c Inc.
• Zymo Research Corporation
How has the global DNA methylation market performed 
so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in 
the global DNA methylation market?
What is the impact of each driver, restraint, and 
Key opportunity on the global DNA methylation market?
Questions What are the key regional markets?
Answered in 
Which countries represent the most attractive DNA 
methylation market?
the Report
What is the breakup of the market based on the 
product?
Which is the most attractive product in the DNA 
methylation market?
What is the breakup of the market based on the 
technology?
Which is the most attractive technology in the DNA 
methylation market?
What is the breakup of the market based on the 
application?
Which is the most attractive application in the DNA 
Key methylation market?
Questions What is the breakup of the market based on the end user?
Answered in Which is the most attractive end user in the DNA 
methylation market?
the Report
What is the competitive structure of the market?
Who are the key players/companies in the global DNA 
methylation market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  D N A  M e t h y l a t i o n  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     C o n s u m a b l e s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     K i t s  a n d  R e a g e n t s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     E n z y m e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     I n s t r u m e n t  a n d  S o f t w a r e
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7     M a r k e t  B r e a k u p  b y  T e c h n o l o g y
    7 . 1     P o l y m e r a s e  C h a i n  R e a c t i o n  ( P C R )
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     M i c r o a r r a y
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
Table of     7 . 3     S e q u e n c i n g        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     O t h e r s
Contents         7 . 4 . 1  M a r k e t  T r e n d s        7 . 4 . 2  M a r k e t  F o r e c a s t
8     M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     G e n e  T h e r a p y
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     C l i n i c a l  R e s e a r c h
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     D i a g n o s t i c s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     O t h e r s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / d n a - m et h y l a t i o n - m a r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]